Literature DB >> 4012943

[Classification, histologic and cytologic grading and regression grading of prostate cancer].

B Helpap, A Böcking, G Dhom, P Faul, H Kastendieck, W Leistenschneider, H A Müller.   

Abstract

The submitted recommendation of the pathologic- urologic team "prostatic carcinoma" is the result of several meetings, in order to provide a basis for a uniform nomenclature in diagnosis, therapy, and prognosis of prostatic carcinoma to urologists and pathologists in practice.

Entities:  

Mesh：

Year:  1985        PMID： 4012943

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  4 in total

1.  [Therapy induced regressive changes of prostate cancer].

Authors:  B Helpap; J Köllermann
Journal:  Pathologe       Date:  2004-11       Impact factor: 1.011

2.  [Documentation quality of histopathology reports of prostate needle biopsies: a snapshot].

Authors:  S Biesterfeld
Journal:  Urologe A       Date:  2014-11       Impact factor: 0.639

3.  The value of prognostic factors in prostatic cancer.

Authors:  J Schubert; S Kowalik
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

4.  Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer.

Authors:  Jens Kollermann; Carsten Kempkensteffen; Burkhard Helpap; Mark Schrader; Hans Krause; Markus Muller; Kurt Miller; Martin Schostak
Journal:  BMC Urol       Date:  2006-06-27       Impact factor: 2.264
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.